Ophthalmology

2016/02/26MEDICAL UPDATE

High-dose statin treatment improves symptoms of macular degeneration

by Bruce Sylvester: Investigators from a phase l/II clinical trial report that high-dose atorvastatin treatment of patients with the dry form of age-related macular degeneration (AMD) resulted in a regression of lipid deposits and improvement in visual acuity, without progression to advanced disease.

READ MORE

2015/05/01MEDICAL UPDATE

Eyesight in MS protected by epilepsy drug

by Bruce Sylvester: Phenytoin, a drug used to prevent seizures in epilepsy, appears to help protect the eyesight of persons with multiple sclerosis (MS).  Researchers reported this finding in a study presented on April 16, 2015 at the American Academy of Neurology’s 67th Annual Meeting.

READ MORE

2015/02/26MEDICAL UPDATE

Ranibizumab appears to reverse diabetes-related vision loss in some populations

by Bruce Sylvester: Ranibizumab (Lucentis®) therapy appears to have efficacy in reversing diabetes-related vision loss in some populations, researchers reported online on Feb. 19 in the journal Opthalmology.

READ MORE

2014/07/29MEDICAL UPDATE

Press Release: OZURDEX® Receives European positive opinion for the treatment of the sight threatening condition, Diabetic Macular Oedema (DME)

Sustained release treatment option could soon be available for diabetic patients in 28 countries of the European Union.  

READ MORE

2013/11/14MEDICAL UPDATE

FDA Highlights: Adalimumab reduces inflammation in refractory pediatric uveitis

Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS)  that treatment with adalimumab may be effective for patients with steroid-resistant refractory pediatric uveitis.

READ MORE

2013/08/19MEDICAL UPDATE

Questions answered with the pupils of your eyes

Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system—consisting of just a laptop and camera—that measures nothing but the size of their pupils.

READ MORE

2013/05/10MEDICAL UPDATE

Topical application of rheumatoid arthritis drug anakinra offers relief in dry eye disease

FDA Highlights by Bruce Sylvester - Researchers from the Massachusetts Eye and Ear, Harvard Medical School, and Brigham and Women's hospital in Boston, Massachusetts report that topical anakinra, a recombinant version of human IL-1Ra FDA-approved for treatment of rheumatoid arthritis, significantly reduced dry eye disease (DED) symptoms in a new clinical trial.

READ MORE

2013/03/06MEDICAL UPDATE

New genetic risk factors for AMD

An international group of investigators has identified seven new genetic regions associated with age-related macular degeneration (AMD), a common cause of blindness in older individuals. The findings could point to new biological pathways and therapeutic targets for AMD.

READ MORE

2012/12/13MEDICAL UPDATE

Is glaucoma increasing road traffic accident rates?

by Gary Finnegan - World Health Matters (Japan) - Researchers in Japan have called for mandatory visual field testing for drivers in light of evidence showing glaucoma may increase the risk of road traffic accidents.

READ MORE